BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 33277571)

  • 21. An Lysophosphatidic Acid Receptors 1 and 3 Axis Governs Cellular Senescence of Mesenchymal Stromal Cells and Promotes Growth and Vascularization of Multiple Myeloma.
    Kanehira M; Fujiwara T; Nakajima S; Okitsu Y; Onishi Y; Fukuhara N; Ichinohasama R; Okada Y; Harigae H
    Stem Cells; 2017 Mar; 35(3):739-753. PubMed ID: 27641212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Requirement of Osteopontin in the migration and protection against Taxol-induced apoptosis via the ATX-LPA axis in SGC7901 cells.
    Zhang R; Wang J; Ma S; Huang Z; Zhang G
    BMC Cell Biol; 2011 Mar; 12():11. PubMed ID: 21406114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid.
    Kishi Y; Okudaira S; Tanaka M; Hama K; Shida D; Kitayama J; Yamori T; Aoki J; Fujimaki T; Arai H
    J Biol Chem; 2006 Jun; 281(25):17492-17500. PubMed ID: 16627485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological roles of lysophosphatidic acid signaling through its production by autotaxin.
    Okudaira S; Yukiura H; Aoki J
    Biochimie; 2010 Jun; 92(6):698-706. PubMed ID: 20417246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autotaxin is induced by TSA through HDAC3 and HDAC7 inhibition and antagonizes the TSA-induced cell apoptosis.
    Li S; Wang B; Xu Y; Zhang J
    Mol Cancer; 2011 Feb; 10():18. PubMed ID: 21314984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro.
    Schmid R; Wolf K; Robering JW; Strauß S; Strissel PL; Strick R; Rübner M; Fasching PA; Horch RE; Kremer AE; Boos AM; Weigand A
    BMC Cancer; 2018 Dec; 18(1):1273. PubMed ID: 30567518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FOXF1 transcription factor promotes lung morphogenesis by inducing cellular proliferation in fetal lung mesenchyme.
    Ustiyan V; Bolte C; Zhang Y; Han L; Xu Y; Yutzey KE; Zorn AM; Kalin TV; Shannon JM; Kalinichenko VV
    Dev Biol; 2018 Nov; 443(1):50-63. PubMed ID: 30153454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Expression Regulation and Biological Function of Autotaxin.
    Zhang X; Li M; Yin N; Zhang J
    Cells; 2021 Apr; 10(4):. PubMed ID: 33921676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autotaxin determines colitis severity in mice and is secreted by B cells in the colon.
    Lin S; Haque A; Raeman R; Guo L; He P; Denning TL; El-Rayes B; Moolenaar WH; Yun CC
    FASEB J; 2019 Mar; 33(3):3623-3635. PubMed ID: 30481488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of the lysophosphatidic acid-generating enzyme autotaxin in lymphocyte-endothelial cell interactions.
    Nakasaki T; Tanaka T; Okudaira S; Hirosawa M; Umemoto E; Otani K; Jin S; Bai Z; Hayasaka H; Fukui Y; Aozasa K; Fujita N; Tsuruo T; Ozono K; Aoki J; Miyasaka M
    Am J Pathol; 2008 Nov; 173(5):1566-76. PubMed ID: 18818380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High Glucose Induces VEGF-C Expression via the LPA1/3-Akt-ROS-LEDGF Signaling Axis in Human Prostate Cancer PC-3 Cells.
    Huang YL; Lin YC; Lin CC; Chen WM; Chen BPC; Lee H
    Cell Physiol Biochem; 2018; 50(2):597-611. PubMed ID: 30317243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autotaxin-lysophosphatidic acid signaling axis mediates tumorigenesis and development of acquired resistance to sunitinib in renal cell carcinoma.
    Su SC; Hu X; Kenney PA; Merrill MM; Babaian KN; Zhang XY; Maity T; Yang SF; Lin X; Wood CG
    Clin Cancer Res; 2013 Dec; 19(23):6461-72. PubMed ID: 24122794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autotaxin and LPA receptors represent potential molecular targets for the radiosensitization of murine glioma through effects on tumor vasculature.
    Schleicher SM; Thotala DK; Linkous AG; Hu R; Leahy KM; Yazlovitskaya EM; Hallahan DE
    PLoS One; 2011; 6(7):e22182. PubMed ID: 21799791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ATX‑LPA axis facilitates estrogen‑induced endometrial cancer cell proliferation via MAPK/ERK signaling pathway.
    Zhang G; Cheng Y; Zhang Q; Li X; Zhou J; Wang J; Wei L
    Mol Med Rep; 2018 Mar; 17(3):4245-4252. PubMed ID: 29328374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis.
    Yang F; Chen GX
    World J Gastroenterol; 2018 Sep; 24(36):4132-4151. PubMed ID: 30271079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the autotaxin - Lysophosphatidic acid receptor axis in cardiovascular diseases.
    Zhao Y; Hasse S; Zhao C; Bourgoin SG
    Biochem Pharmacol; 2019 Jun; 164():74-81. PubMed ID: 30928673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Forkhead box F1 is essential for migration of mesenchymal cells and directly induces integrin-beta3 expression.
    Malin D; Kim IM; Boetticher E; Kalin TV; Ramakrishna S; Meliton L; Ustiyan V; Zhu X; Kalinichenko VV
    Mol Cell Biol; 2007 Apr; 27(7):2486-98. PubMed ID: 17261592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New insights into the autotaxin/LPA axis in cancer development and metastasis.
    Leblanc R; Peyruchaud O
    Exp Cell Res; 2015 May; 333(2):183-189. PubMed ID: 25460336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Function and biological activities of the autotaxin-LPA axis].
    Li ZW; Zhao YR; Zhao C; Fu R; Li ZY
    Sheng Li Xue Bao; 2011 Dec; 63(6):601-10. PubMed ID: 22193457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The autotaxin-lysophosphatidic acid pathway in pathogenesis of rheumatoid arthritis.
    Orosa B; García S; Conde C
    Eur J Pharmacol; 2015 Oct; 765():228-33. PubMed ID: 26297977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.